Rhodopsin (RHO) Antibody

Documentos del producto

Especificaciones del producto

Primary Antibodies

Target: Rhodopsin (RHO)
Immunogen: Synthesized peptide derived from human Rhodopsin around the non-phosphorylation site of S334.

Rabbit

Human, Mouse, Rat

ELISA: 1/5000, WB: 1/500 - 1/2000, IHC: 1/100 - 1/300. Optimal dilutions/concentrations should be determined by the end user.

Polyclonal

Unconjugated

IgG

Purified by affinity chromatography.

50 µg

100 µg

Liquid

ELISA, WB, IHC

PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.

Shipped within 5-10 working days.

Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.

No

P08100

6010

RHO,RP4,OPN2,CSNBAD1

Antibody anti-RHO

RUO

THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

Rhodopsin (RHO) is a light-sensitive G protein-coupled receptor found in the rod cells of the retina, which plays a crucial role in vision, especially in low-light conditions. It is composed of the protein opsin and a retinal chromophore. When light hits rhodopsin, the retinal undergoes a conformational change, activating the opsin and initiating a signaling cascade that results in hyperpolarization of the rod cell and the transmission of visual signals to the brain. Rhodopsin is highly sensitive to light, making it essential for scotopic vision, or vision in dim light. Mutations in the RHO gene can lead to various retinal diseases, including retinitis pigmentosa, which causes progressive vision loss and, eventually, blindness. Research into rhodopsin and its mechanisms is important for understanding retinal diseases and developing potential therapies to treat them, including gene therapies and pharmacological interventions to restore or protect vision.